|HighTech Gründerfunds||Investment Manager||Allemagne|
What is the best background for an academic spin-off CEO?
He adds significant experience in the biotech field with the focus on the development of biologicals from manufacturing up to clinical trials.
- Dr. Frank Hensel studied biology with graduation in Biophysics at the University of Osnabrück he started is Ph.D. thesis in area of tumorreactive antibodies at the University of Würzburg.
- 2007 – 2015
- Managing director Patrys GmbH in Würzburg.
- 2001 – 2007
- Co-Founder and CEO OncoMab GmbH.